胃癌传统胃切除术后糖尿病缓解与复发的预测因素:全国性人群队列研究
该全国性队列纳入2004至2014年间因胃癌行胃切除术的5150例糖尿病患者,评估术前临床参数对糖尿病缓解与复发的预测作用及术后体重变化的影响。六项因素可显著预测缓解,三项因素预测复发,术后体重下降幅度较大与缓解可能性增加独立相关。
要点
- 六项术前因素(较高BMI、全胃切除、较年轻、FPG水平、OHA数量、未用胰岛素)可预测糖尿病缓解。
- 三项因素(较年轻、较低FPG、仅用1种OHA)与糖尿病复发风险降低相关。
- 术后BMI下降幅度较大者糖尿病缓解可能性更高,且独立于基线BMI。
核心结论
- 六项变量可显著预测胃癌胃切除术后糖尿病缓解,三项变量可预测复发。
- 术后体重下降幅度较大可能增加糖尿病缓解可能性,且独立于基线体重。
研究设计与样本
- 全国性人群队列研究,纳入2004至2014年间因胃癌行胃切除术的糖尿病患者5150例。
- 糖尿病缓解依据术后降糖药物使用及空腹血糖水平以3种方式定义。
- 糖尿病复发定义为已达缓解的患者重新启用降糖药物。
主要发现
- 六项缓解预测因素(较高BMI、全胃切除、较年轻、FPG水平、OHA数量、未用胰岛素)使缓解可能性增加超过13倍(OR 13.67;95%CI 8.65‒19.11)。
- 三项因素(较年轻、较低FPG、仅用1种OHA)预测复发可能性降低58%(HR 0.42;95%CI 0.35‒0.48)。
- 术后BMI下降最低区间(<-20%)者缓解可能性为最高区间(≥-5%)的3倍以上(OR 3.14;95%CI 2.08‒4.75),独立于基线BMI。
临床怎么用
- 可利用术前BMI、手术类型、年龄、FPG、OHA数量及胰岛素使用情况评估术后糖尿病缓解与复发风险。
- 术后体重管理策略可参考体重下降幅度与糖尿病缓解的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated whether preoperative clinical parameters predict diabetes remission and relapse after conventional gastrectomy for cancer and whether postoperative weight changes influence diabetes remission and relapse. STUDY DESIGN: This study included 5,150 patients with diabetes who underwent gastrectomy for cancer from 2004 to 2014. Diabetes remission was defined in 3 ways, according to postoperative antidiabetic medication and fasting plasma glucose (FPG) levels. Diabetes relapse was defined as reinitiating antidiabetic medication among patients in diabetes remission. RESULTS: Six predictors (higher body mass index [BMI], total gastrectomy, younger age, FPG levels, number of oral hypoglycemic agents [OHAs], and no insulin use) of diabetes remission increased the likelihood of remission by >13-fold (odds ratio [OR], 13.67; 95% confidence interval [CI], 8.65‒19.11). Three factors (younger age, lower FPG levels, and use of only 1 OHA) predicted a 58% decreased likelihood of diabetes relapse (hazard ratio, 0.42; 95% CI 0.35‒0.48). The lowest interval of postoperative BMI decrease (<-20%) showed a >3-fold increased likelihood of diabetes remission than the highest interval (≥-5%; OR 3.14; 95% CI 2.08‒4.75), independent of baseline BMI. CONCLUSIONS: Six variables (BMI, type of gastrectomy, age, FPG levels, number of OHAs used, and insulin use/non-use), and 3 variables (age, FPG levels, number of OHAs used) significantly predict diabetes remission and relapse after gastrectomy for cancer, respectively. Greater postoperative weight decrease may increase the likelihood of diabetes remission, independent of baseline weight. Our results may serve as a basis for the establishment of diabetes and weight management strategies after conventional gastrectomy for cancer.
引用
- Kwon Y, Kwon JW, Kim D, et al. Predictors of Remission and Relapse of Diabetes after Conventional Gastrectomy for Gastric Cancer: Nationwide Population-Based Cohort Study. J Am Coll Surg. 2021. PMID: 33831541. doi:10.1016/j.jamcollsurg.2021.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。